|
||
Journal of Experimental Medicine, Vol 155, 1579-1584, Copyright © 1982 by Rockefeller University Press
ARTICLES |
U Landegren, U Ramstedt, I Axberg, M Ullberg, M Jondal and H Wigzell
Out of a panel of seven monoclonal antibodies with affinity for human lymphoid cells, three were shown to prevent cytotoxic T cell activity, whereas none affected natural killer cell activity when applied without complement. Anti-OKT3 and anti-Leu-2a, with affinity for all T cells and the cytotoxic/suppressive subset, respectively were both shown to inhibit T killing by their interaction with the effector cell. For anti- OKT3, the inhibition remained after free antibody was washed away. Anti- Leu-2a, in contrast, induced a rapidly reversible inhibition. Using a single cell assay, anti-OKT3 was shown to reduce the lytic ability without affecting target cell binding, whereas anti-Leu-2a prevented the effectors from binding target cells.
This article has been cited by other articles:
| TABLE OF CONTENTS |
|